28-Jun-2021
Change of Director's Interest Notice Change of Director's Interest Notice

22-Jun-2021
Results of Meeting Results of Meeting

22-Jun-2021
AGM Chairman's Address and CEO Presentation AGM Chairman's Address and CEO Presentation

16-Jun-2021
Change of Director's Interest Notice Change of Director's Interest Notice

15-Jun-2021
Investor presentation, 15 June 2021 Investor presentation, 15 June 2021

15-Jun-2021
Initial Director's Interest Notice Initial Director's Interest Notice

15-Jun-2021
Neuren CEO Jon Pilcher appointed to board of directors Neuren CEO Jon Pilcher appointed to board of directors

10-Jun-2021
Neuren to present at MST Access investor conference Neuren to present at MST Access investor conference

10-Jun-2021
Update - Annual General Meeting 2021 Update - Annual General Meeting 2021

1-Jun-2021
Positive FDA meetings enable INDs for three Phase 2 trials Positive FDA meetings enable INDs for three Phase 2 trials